These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19573286)

  • 1. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation syndrome.
    Rizk B
    Reprod Biomed Online; 2009 Jul; 19(1):14-27. PubMed ID: 19573286
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of severity of symptoms in iatrogenic ovarian hyperstimulation syndrome by follicle-stimulating hormone receptor Ser680Asn polymorphism.
    Daelemans C; Smits G; de Maertelaer V; Costagliola S; Englert Y; Vassart G; Delbaere A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6310-5. PubMed ID: 15579795
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome.
    Kerkelä E; Skottman H; Friden B; Bjuresten K; Kere J; Hovatta O
    Fertil Steril; 2007 Mar; 87(3):603-6. PubMed ID: 17074323
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of FSH receptor and CYP19A1 gene variations with sterility and ovarian hyperstimulation syndrome.
    Binder H; Dittrich R; Hager I; Müller A; Oeser S; Beckmann MW; Hamori M; Fasching PA; Strick R
    Reproduction; 2008 Jan; 135(1):107-16. PubMed ID: 18159088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inferring biallelism of two FSH receptor mutations associated with spontaneous ovarian hyperstimulation syndrome by evaluating FSH, LH and HCG cross-activity.
    Lazzaretti C; Riccetti L; Sperduti S; Anzivino C; Brigante G; De Pascali F; Potì F; Rovei V; Restagno G; Mari C; Lussiana C; Benedetto C; Revelli A; Casarini L
    Reprod Biomed Online; 2019 May; 38(5):816-824. PubMed ID: 30910395
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian hyperstimulation syndrome (OHSS) due to mutations in the follicle-stimulating hormone receptor.
    Rodien P; Beau I; Vasseur C
    Ann Endocrinol (Paris); 2010 May; 71(3):206-9. PubMed ID: 20362966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular pathology of the FSH receptor: new insights into FSH physiology.
    Meduri G; Bachelot A; Cocca MP; Vasseur C; Rodien P; Kuttenn F; Touraine P; Misrahi M
    Mol Cell Endocrinol; 2008 Jan; 282(1-2):130-42. PubMed ID: 18248882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations and polymorphisms of the FSH receptor (FSHR) gene: clinical implications in female fecundity and molecular biology of FSHR protein and gene.
    Lussiana C; Guani B; Mari C; Restagno G; Massobrio M; Revelli A
    Obstet Gynecol Surv; 2008 Dec; 63(12):785-95. PubMed ID: 19017414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The N680S variant in the follicle-stimulating hormone receptor gene identifies hyperresponders to controlled ovarian stimulation.
    Nenonen HA; Lindgren IA; Prahl AS; Trzybulska D; Kharraziha I; Hultén M; Giwercman YL; Henic E
    Pharmacogenet Genomics; 2019 Jul; 29(5):114-120. PubMed ID: 30829738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two different entities of spontaneous ovarian hyperstimulation in a woman with FSH receptor mutation.
    Dieterich M; Bolz M; Reimer T; Costagliola S; Gerber B
    Reprod Biomed Online; 2010 Jun; 20(6):751-8. PubMed ID: 20378412
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Ser680Asn polymorphism in the follicle-stimulating hormone receptor gene is associated with the ovarian response in controlled ovarian hyperstimulation.
    Huang X; Li L; Hong L; Zhou W; Shi H; Zhang H; Zhang Z; Sun X; Du J
    Clin Endocrinol (Oxf); 2015 Apr; 82(4):577-83. PubMed ID: 25132286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights in mechanisms for development of ovarian hyperstimulation syndrome.
    Kasum M
    Coll Antropol; 2010 Sep; 34(3):1139-43. PubMed ID: 20977119
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence and absence of follicle-stimulating hormone receptor mutations provide some insights into spontaneous ovarian hyperstimulation syndrome physiopathology.
    De Leener A; Montanelli L; Van Durme J; Chae H; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2006 Feb; 91(2):555-62. PubMed ID: 16278261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Apr; 89(4):1255-8. PubMed ID: 15080154
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mutation in the follicle-stimulating hormone receptor as a cause of familial spontaneous ovarian hyperstimulation syndrome.
    Montanelli L; Delbaere A; Di Carlo C; Nappi C; Smits G; Vassart G; Costagliola S
    J Clin Endocrinol Metab; 2004 Mar; 89(3):1255-8. PubMed ID: 15001619
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spontaneous and iatrogenic ovarian hyperstimulation syndrome in the absence of FSHR mutations: a case report of two unexpected cases.
    Daolio J; Sperduti S; Casarini L; Falbo A; Materazzo C; Aguzzoli L; Villani MT
    BMC Med Genomics; 2023 Mar; 16(1):45. PubMed ID: 36882810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome.
    Rizk B; Aboulghar M; Smitz J; Ron-El R
    Hum Reprod Update; 1997; 3(3):255-66. PubMed ID: 9322101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of the first germline mutation in the extracellular domain of the follitropin receptor responsible for spontaneous ovarian hyperstimulation syndrome.
    De Leener A; Caltabiano G; Erkan S; Idil M; Vassart G; Pardo L; Costagliola S
    Hum Mutat; 2008 Jan; 29(1):91-8. PubMed ID: 17721928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between the luteinizing hormone/chorionic gonadotropin receptor (LHCGR) rs4073366 polymorphism and ovarian hyperstimulation syndrome during controlled ovarian hyperstimulation.
    O'Brien TJ; Kalmin MM; Harralson AF; Clark AM; Gindoff I; Simmens SJ; Frankfurter D; Gindoff P
    Reprod Biol Endocrinol; 2013 Jul; 11():71. PubMed ID: 23883350
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian hyper-stimulation syndrome after spontaneous conception.
    Lussiana C; Guani B; Restagno G; Rovei V; Menato G; Revelli A; Massobrio M
    Gynecol Endocrinol; 2009 Jul; 25(7):455-9. PubMed ID: 19499413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.